Trials / Sponsors / Cellect Biotechnology
Cellect Biotechnology
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Non Hodgkin Lymphoma (NHL) | — | 2018-06-10 |
| Unknown | Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplanta Hematological Malignancies | Phase 1 / Phase 2 | 2017-01-01 |